National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 34543-34544 [2017-15509]
Download as PDF
Federal Register / Vol. 82, No. 141 / Tuesday, July 25, 2017 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notification Process for Availability of
Test Tools and Test Procedures
Approved by the National Coordinator
for the ONC Health IT Certification
Program IT Certification Program
Office of the National
Coordinator for Health Information
Technology (ONC), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
This notice announces a
change in the notification process for
the availability of test tools and test
procedures approved by the National
Coordinator for Health Information
Technology for the testing of health IT
under the ONC Health IT Certification
Program.
FOR FURTHER INFORMATION CONTACT:
Alicia Morton, Director, ONC Health IT
Certification Program, Office of the
National Coordinator for Health
Information Technology, 202–690–7151.
SUPPLEMENTARY INFORMATION: On
January 7, 2011, the Department of
Health and Human Services issued a
final rule establishing a permanent
certification program for the purposes of
testing and certifying health information
technology (‘‘Establishment of the
Permanent Certification Program for
Health Information Technology,’’ (76 FR
1262) (‘‘Permanent Certification
Program final rule’’)). The Permanent
Certification Program was renamed the
ONC HIT Certification Program in a
final rule published on September 4,
2012 (77 FR 54163) (‘‘2014 Edition final
rule’’), and subsequently renamed the
ONC Health IT Certification Program
(‘‘Program’’) in a final rule published on
October 16, 2015 (80 FR 62601) (‘‘2015
Edition final rule’’). In the preamble
ofthe Permanent Certification Program
final rule, we stated that when the
National Coordinator for Health
Information Technology (National
Coordinator) had approved test tools
and test procedures for certification
criteria adopted by the Secretary, ONC
would publish a notice of availability in
the Federal Register and identify the
approved test tools and test procedures
on the ONC Web site.
The public notification of the
availability of approved test tools and
test procedures is an operational aspect
of the process ONC adopted in
rulemaking for approving test tools and
test procedures. To date, we have found
that health IT stakeholders prefer to be
notified via ONC’s normal
communication channels (listserv and
Web site updates) and more frequently
mstockstill on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:30 Jul 24, 2017
Jkt 241001
visit the ONC Health IT Certification
Program’s Web page for up-to-date
Program information. Thus, to improve
the efficiency and effectiveness of
Program operations, ONC will now
begin notifying the public of the
availability of approved test tools and
test procedures via our listserv. ONC
will also continue to identify approved
test tools and test procedures on the
ONC Web site, including test data
approved for the testing ofhealth IT
under the Program (76 FR 1280 and 80
FR 32477). The new approach will
enable ONC to more effectively and
timely reach interested parties,
particularly health IT developers.
Health IT developers and other
interested parties can sign up for the
Program listserv at https://public. gov
delivery.cornlaccounts/USHHSONC/
subscriber/new?category id=USHH
SONC C8.
Authority: 42 U.S.C. 300jj–11.
Dated: July 13, 2017.
Donald W. Rucker,
National Coordinator for Health Information
Technology.
[FR Doc. 2017–15566 Filed 7–24–17; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 BTRC Review
(2018/01).
Date: September 28, 2017.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Suite 920, Bethesda, MD 20892
(Virtual Meeting)
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
34543
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Suite 959, Bethesda,
MD 20892, (301) 451–3397, sukharem@
mail.nih.gov.
Dated: July 19, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–15510 Filed 7–24–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Heart, Lung, and Blood
Advisory Council. The meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: August 29, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 9100, Bethesda, MD
20892, (Teleconference).
Contact Person: Laura K. Moen, Ph.D.,
Director, Division of Extramural Research
Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7100, Bethesda, MD
20892, 301–435–0260, moenl@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/nhlbac/
index.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
E:\FR\FM\25JYN1.SGM
25JYN1
34544
Federal Register / Vol. 82, No. 141 / Tuesday, July 25, 2017 / Notices
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: July 19, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–15509 Filed 7–24–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
mstockstill on DSK30JT082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
Council of Councils.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting Web site (https://
videocast.nih.gov).
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Council of Councils.
Open: September 1, 2017.
Time: 8:15 a.m. to 12:00 p.m.
Agenda: Call to Order and Introductions;
Announcements and Updates; Invited
Speaker Presentation; A Study of Variability
in Scientific Grant Peer Review; NIH Update
and Discussion; Common Fund Concept
Update and Vote.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Closed: September 1, 2017.
Time: 12:30 p.m. to 1:30 p.m.
Agenda: Review of Grant Applications.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
VerDate Sep<11>2014
19:30 Jul 24, 2017
Jkt 241001
Floor, Conference Room 10, Bethesda, MD
20892.
Open: September 1, 2017.
Time: 1:30 p.m. to 4:00 p.m.
Agenda: Council Operating Procedures;
Update—All of UsSM Research Program;
Update on the Office of Research on
Women’s Health (ORWH) Strategic Planning
Process; Sexual and Gender Minority
Research Office (SGMRO) Update; Report
from the Sexual and Gender Minority
Research Working Group; Retiring Council
Members’ Perspectives; Closing Remarks.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Franziska Grieder, D.V.M.,
Ph.D., Executive Secretary, Director, Office of
Research Infrastructure Programs, Division of
Program Coordination, Planning, and
Strategic Initiatives, Office of the Director,
NIH, 6701 Democracy Boulevard, Room 948,
Bethesda, MD 20892, GriederF@mail.nih.gov,
301–435–0744.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Council of Council’s home page at https://
dpcpsi.nih.gov/council/ where an agenda
will be posted before the meeting date.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training, Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: July 19, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–15511 Filed 7–24–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Immune Mechanism.
Date: August 1, 2017.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call)
Contact Person: Scott Jakes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892301–495–
1506, jakesse@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Program
Project: Support of NIGMS Program Project
Grants.
Date: August 2, 2017.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting)
Contact Person: Kenneth A Roebuck, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Pathogenesis and Treatments of Eye
Diseases.
Date: August 21, 2017.
Time: 10:00 a.m. to 5:00 p.m.
E:\FR\FM\25JYN1.SGM
25JYN1
Agencies
[Federal Register Volume 82, Number 141 (Tuesday, July 25, 2017)]
[Notices]
[Pages 34543-34544]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15509]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Heart, Lung, and Blood Advisory Council. The meeting will be
closed to the public in accordance with the provisions set forth in
sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The
grant applications and the discussions could disclose confidential
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Advisory
Council.
Date: August 29, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive, Room
9100, Bethesda, MD 20892, (Teleconference).
Contact Person: Laura K. Moen, Ph.D., Director, Division of
Extramural Research Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701 Rockledge Drive, Room
7100, Bethesda, MD 20892, 301-435-0260, moenl@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.nhlbi.nih.gov/meetings/nhlbac/index.htm, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
[[Page 34544]]
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: July 19, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-15509 Filed 7-24-17; 8:45 am]
BILLING CODE 4140-01-P